Worldwide Clinical Trials Expert to Lead Roundtable Discussion at World Orphan Drug Congress

Tuesday, April 11, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

MORRISVILLE, North Carolina, April 11, 2017 /PRNewswire/ --

Leslie Wetherell, Executive

Director, Project Management and Rare Disease Franchise Lead at Worldwide Clinical Trials (http://www.worldwide.com), will lead a roundtable discussion, titled "Overcoming Operational Challenges in Rare Disease Trials," during the World Orphan Drug
Congress (WODC) 2017, being held April 19-21 in Washington D.C.

Drawing upon more than 20 years of expertise within the pharmaceutical industry, including operational experience in over 40 countries, Wetherell's WODC roundtable discussion will explore the unique operational challenges of rare disease trials. Topics will include challenges with feasibility, patient pathways, patient and site engagement, and quality. Wetherell will lead the discussion on Thursday, April 20 at 12:40 p.m. ET at roundtable #8.

"There continues to be increasing interest around rare disease clinical research, both because of the need to discover therapies to help patients in need, and also because of favorable changes in regulatory guidance that opens up a quicker path to market for rare disease drugs," explained Wetherell. "However, rare disease clinical trials present some unique challenges, which is what we'll be exploring during the WODC roundtable."

More than 150 speakers from across the globe will address the 1,000 WODC attendees, who are professionals from big pharma, biotech, payers, patient groups, academics and government bodies. They will explore emerging trends in orphan disease research and scientific breakthroughs in digital health, biosimilars, gene therapy, and more. Worldwide, which has participated in the design, execution, and analysis of more than 50 studies in orphan diseases, will showcase its services at WODC booth #311.

Connect with Worldwide Clinical Trials: 

  • Tweet: @worldwidetrials to lead discussion on operational challenges in #raredisease trials at World Orphan Drug Congress @OrphanConf
  • Follow us on Twitter: @worldwidetrials
  • Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-

About Worldwide Clinical Trials  

Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit Worldwide.com.

SOURCE Worldwide Clinical Trials



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook